Sigrima 420 mg Injection is a monoclonal antibody designed to recognize and attach to specific proteins on the surface of cancer cells. Sigrima 420mg Injection gets attached to human epidermal growth factor receptor 2 (HER2) and may kill or stop the growth of cancer cells.